U.S. market Closed. Opens in 1 day 5 hours 13 minutes

CLRB | Cellectar Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-11.00K33.33K96.31K125.97KN/AN/A12.58K4.96K
Cost of Revenue192.38K238.87K227.64K207.93K189.36K82.27K1.55M356.67K362.50KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.54K
Gross Profit-192.38K-238.87K-227.64K-207.93K-189.36K-82.27K-1.55M-356.67K-362.50KN/AN/AN/A-11.00K33.33K96.31K125.97KN/AN/A12.58K2.42K
Operating Expenses38.96M28.81M24.13M15.29M14.18M11.66M13.60M9.45M8.55M9.67M11.30M8.75M6.29M5.48M10.26M16.72M20.29M8.93M2.58M627.64K
Selling, General & Admin11.69M9.59M6.54M5.15M5.18M4.82M4.14M4.70M3.40M3.70M4.44M3.63M2.69M2.49M2.18M2.19M2.87M2.49M1.44M365.88K
Research & Development27.27M19.22M17.59M10.14M9.00M6.84M9.47M4.75M5.16M5.96M6.86M5.12M3.60M3.00M8.08M14.53M17.43M6.44M1.14M261.77K
Other Operating ExpensesN/AN/A6.63KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-38.96M-28.81M-24.13M-15.29M-14.18M-13.33M-13.60M-9.45M-8.76M-9.89M-12.40M-8.75M-7.04M-5.45M-10.17M-16.59M-20.29M-8.93M-5.09M-625.22K
Other Expenses / Income917.15K152.52K8.92K196.18K85.71K91.74K38.68K3.27M3.26M1.78M522.76K-42.19K-1.89M-7.20M-12.11M139.61K737.05K382.63K-487.02K-190.07K
Before Tax Income-38.04M-28.66M-24.12M-15.09M-14.09M-13.24M-13.56M-6.18M-5.50M-8.11M-10.78M-8.80M-7.75M-12.65M-26.28M-22.96M-29.72M-8.55M-3.16M-815.28K
Income Tax Expenses-60.00K-60.00K-152.20K-337.63K-218.51K-1.55M-38.68K-3.27M-3.42M-1.56M-522.76K9.34K1.14M-7.55M12.11M-139.61K-737.05K-643.75K487.02KN/A
Net Income-37.98M-28.60M-23.97M-14.76M-13.87M-13.24M-13.56M-6.18M-5.50M-8.11M-10.78M-8.80M-7.44M2.10M-22.27M-16.45M-19.56M-8.29M-3.05M-815.28K
Interest ExpensesN/AN/AN/AN/AN/A29.69K16.61K7.90K841.00446.31K9.35K9.34K430.02K2.42K1.01K130.61KN/AN/AN/A208.74K
Basic Shares Outstanding12.22M7.06M5.55M1.98M767.51K296.20K140.31K43.67K7.82K4.59K2.79K2.06K1.20K147.0022.0014.0012.0012.0012.004.00
Diluted Shares Outstanding12.22M7.06M5.55M1.98M767.51K296.20K140.31K43.67K7.82K4.59K2.79K2.06K1.20K147.0022.0014.0012.0012.0012.004.00
EBITDA-38.77M-28.67M-23.98M-15.15M-13.90M-13.16M-12.05M-9.09M-8.19M-9.30M-10.88M-8.29M-6.33M-12.96M-10.17M-16.59M-19.54M-8.28M-2.94M-604.01K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%57,519.10%-38,876.20%-10,555.25%-13,170.82%0.00%0.00%-23,371.34%-12,172.63%
EBIT-38.04M-28.66M-24.12M-15.09M-14.09M-14.76M-13.58M-9.44M-8.92M-9.22M-11.30M-8.78M-5.86M-5.45M-10.17M-16.46M-20.29M-8.93M-2.57M-606.54K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%53,286.27%-16,344.46%-10,554.20%-13,067.13%0.00%0.00%-20,394.01%-12,223.78%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙